Dobutamine Use in Heart Failure with Low Blood Pressure

Introduction to Dobutamine Therapy

The European Society of Cardiology recommends the use of dobutamine in patients with acute heart failure and a systolic blood pressure between 90-100 mmHg, as seen in patients with borderline hypotension 1, 2

For patients with a systolic blood pressure greater than 100 mmHg, the European Society of Cardiology guidelines suggest the use of vasodilators as the preferred treatment option 1
For patients with a systolic blood pressure between 90-100 mmHg, the guidelines recommend the use of vasodilators and/or inotropes like dobutamine 1, 2
For patients with a systolic blood pressure less than 90 mmHg, the guidelines suggest considering preload correction with fluids, then inotrope therapy, with dopamine preferred over dobutamine for vasopressor support 3

The American Heart Association suggests that dobutamine should only be initiated in patients who demonstrate signs of tissue hypoperfusion, such as cold or clammy extremities, metabolic acidosis, or declining renal function 4
The European Society of Cardiology recommends that dobutamine be used in patients with persistent congestion or pulmonary edema refractory to diuretics and vasodilators at optimal doses 3

The European Society of Cardiology guidelines recommend starting dobutamine at a dose of 2-3 μg/kg/min without a loading bolus, and titrating the dose by 2-2.5 μg/kg/min every 10-15 minutes based on hemodynamic response 5
The therapeutic range for dobutamine is 2-20 μg/kg/min, with most patients responding within this range 4

The American College of Cardiology recommends continuous monitoring of blood pressure, preferably through an invasive arterial line, in patients receiving dobutamine 3
The European Society of Cardiology suggests monitoring urine output, with a target of greater than 100 mL/hour in the first 2 hours 3

The European Society of Cardiology recommends considering levosimendan as an alternative to dobutamine in patients with hypotension, as it has vasodilator properties but may be better tolerated 1
The American Heart Association suggests considering dopamine as an alternative to dobutamine in patients with severe hypotension, as it provides more vasopressor support at higher doses 4

The European Society of Cardiology guidelines recommend withdrawing dobutamine as soon as adequate organ perfusion is restored and/or congestion reduced, with gradual tapering by 2 μg/kg/min decrements every other day to prevent rebound hypotension 3, 4